• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于聚类分析的 MCAS 临床有意义亚型的识别:热证和寒证的相关性。

Cluster-Analytic Identification of Clinically Meaningful Subtypes in MCAS: The Relevance of Heat and Cold.

机构信息

Institute for Digitalization and General Medicine, University Hospital RWTH Aachen, Aachen, Germany.

Center for Rare Diseases Bonn (ZSEB), University Hospital Bonn, Bonn, Germany.

出版信息

Dig Dis Sci. 2023 Aug;68(8):3400-3412. doi: 10.1007/s10620-023-07921-5. Epub 2023 Apr 8.

DOI:10.1007/s10620-023-07921-5
PMID:37029308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10352424/
Abstract

BACKGROUND

Mast cell activation syndrome (MCAS) is a clinically heterogeneous disease with allergy-like symptoms and abdominal complaints. Its etiology is only partially understood and it is often overlooked.

AIMS

The aim of this study was to identify subgroups of MCAS patients to facilitate diagnosis and allow a personalized therapy.

METHODS

Based on data from 250 MCAS patients, hierarchical and two-step cluster analyses as well as association analyses were performed. The data used included data from a MCAS checklist asking about symptoms and triggers and a set of diagnostically relevant laboratory parameters.

RESULTS

Using a two-step cluster analysis, MCAS patients could be divided into three clusters. Physical trigger factors were particularly decisive for the classification as they showed remarkable differences between the three clusters. Cluster 1, labeled high responders, showed high values for the triggers heat and cold, whereas cluster 2, labeled intermediate responders, presented with high values for the trigger heat and low values for cold. The third cluster, labeled low responders, did not react to thermal triggers. The first two clusters showed more divers clinical symptoms especially with regard to dermatological and cardiological complaints. Subsequent association analyses revealed relationships between triggers and clinical complaints: Abdominal discomfort is mainly triggered by histamine consumption, dermatological discomfort by exercise, and neurological symptoms are related to physical exertion and periods of starvation. The reasons for the occurrence of cardiological complaints are manifold and triggers for respiratory complaints still need better identification.

CONCLUSION

Our study identified three distinct clusters on the basis of physical triggers, which also differ significantly in their clinical symptoms. A trigger-related classification can be helpful in clinical practice for diagnosis and therapy. Longitudinal studies should be conducted to further understand the relationship between triggers and symptoms.

摘要

背景

肥大细胞活化综合征(MCAS)是一种具有过敏样症状和腹部不适的临床异质性疾病。其病因仅部分了解,且常被忽视。

目的

本研究旨在确定 MCAS 患者的亚组,以促进诊断并允许进行个性化治疗。

方法

基于 250 例 MCAS 患者的数据,进行了层次聚类分析和两步聚类分析以及关联分析。使用的数据包括 MCAS 检查表中的症状和触发因素数据以及一组与诊断相关的实验室参数。

结果

使用两步聚类分析,MCAS 患者可分为三组。物理触发因素对分类具有决定性作用,因为它们在三组之间存在显著差异。标记为高反应者的第 1 组表现出对热和冷这两种触发因素的高值,而标记为中反应者的第 2 组表现出对热的高值和对冷的低值。第 3 组标记为低反应者,对热触发无反应。前两组表现出更多样化的临床症状,尤其是皮肤和心脏方面的症状。随后的关联分析揭示了触发因素与临床症状之间的关系:腹部不适主要由组胺消耗引起,皮肤不适主要由运动引起,神经症状与体力消耗和饥饿期有关。心脏症状的发生原因多种多样,呼吸道症状的触发因素仍需更好地确定。

结论

我们的研究基于物理触发因素确定了三个不同的亚组,这些亚组在临床症状上也有显著差异。基于触发因素的分类在临床实践中有助于诊断和治疗。应进行纵向研究以进一步了解触发因素与症状之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/10352424/37972b925e28/10620_2023_7921_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/10352424/32be7b788c49/10620_2023_7921_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/10352424/4d9ac8880a43/10620_2023_7921_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/10352424/b0644301ca4b/10620_2023_7921_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/10352424/37972b925e28/10620_2023_7921_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/10352424/32be7b788c49/10620_2023_7921_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/10352424/4d9ac8880a43/10620_2023_7921_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/10352424/b0644301ca4b/10620_2023_7921_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffb1/10352424/37972b925e28/10620_2023_7921_Fig4_HTML.jpg

相似文献

1
Cluster-Analytic Identification of Clinically Meaningful Subtypes in MCAS: The Relevance of Heat and Cold.基于聚类分析的 MCAS 临床有意义亚型的识别:热证和寒证的相关性。
Dig Dis Sci. 2023 Aug;68(8):3400-3412. doi: 10.1007/s10620-023-07921-5. Epub 2023 Apr 8.
2
Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome.系统性肥大细胞增多症和肥大细胞激活综合征患者的健康相关生活质量和健康素养。
Orphanet J Rare Dis. 2022 Jul 29;17(1):295. doi: 10.1186/s13023-022-02439-x.
3
Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management.肥大细胞活化综合征与肠道功能障碍:诊断与管理。
Curr Gastroenterol Rep. 2024 Apr;26(4):107-114. doi: 10.1007/s11894-024-00924-w. Epub 2024 Feb 14.
4
Idiopathic mast cell activation syndrome is more often suspected than diagnosed-A prospective real-life study.特发性肥大细胞活化综合征的怀疑多于诊断——一项前瞻性真实世界研究。
Allergy. 2022 Sep;77(9):2794-2802. doi: 10.1111/all.15304. Epub 2022 Apr 7.
5
Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.肥大细胞激活综合征:通过联合检测血清胰蛋白酶和 24 小时尿 11β-前列腺素 2α 提高的识别。
J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):775-8. doi: 10.1016/j.jaip.2014.06.011. Epub 2014 Nov 6.
6
[Idiopathic mast cell activation syndrome].[特发性肥大细胞活化综合征]
Ned Tijdschr Geneeskd. 2022 Jan 24;166:D5844.
7
A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders.过敏学家面临的挑战:在肥大细胞疾病中应用过敏诊断方法。
Int J Mol Sci. 2021 Feb 1;22(3):1454. doi: 10.3390/ijms22031454.
8
Using the Right Criteria for MCAS.用正确的标准来诊断肥大细胞激活综合征(MCAS)。
Curr Allergy Asthma Rep. 2024 Feb;24(2):39-51. doi: 10.1007/s11882-024-01126-0. Epub 2024 Jan 20.
9
Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.扩展肥大细胞激活障碍谱:单克隆和特发性肥大细胞激活综合征。
Clin Ther. 2013 May;35(5):548-62. doi: 10.1016/j.clinthera.2013.04.001. Epub 2013 May 1.
10
Mast Cell Activation Syndrome.肥大细胞活化综合征。
Clin Rev Allergy Immunol. 2018 Jun;54(3):353-365. doi: 10.1007/s12016-015-8487-6.

引用本文的文献

1
Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series.肥大细胞活化综合征的神经精神表现及对肥大细胞靶向治疗的反应:病例系列
J Pers Med. 2023 Oct 31;13(11):1562. doi: 10.3390/jpm13111562.

本文引用的文献

1
Translational precision medicine: an industry perspective.转化精准医学:产业视角。
J Transl Med. 2021 Jun 5;19(1):245. doi: 10.1186/s12967-021-02910-6.
2
Precision nutrition: A systematic literature review.精准营养:系统文献回顾。
Comput Biol Med. 2021 Jun;133:104365. doi: 10.1016/j.compbiomed.2021.104365. Epub 2021 Apr 7.
3
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts.肥大细胞作为一种独特的造血谱系和细胞系统:从保罗·埃尔利希的愿景到精准医学概念。
Theranostics. 2020 Aug 29;10(23):10743-10768. doi: 10.7150/thno.46719. eCollection 2020.
4
Mast Cell Activation Syndrome: A Primer for the Gastroenterologist.肥大细胞激活综合征:胃肠病学家入门。
Dig Dis Sci. 2021 Apr;66(4):965-982. doi: 10.1007/s10620-020-06264-9. Epub 2020 Apr 23.
5
Diagnosis of mast cell activation syndrome: a global "consensus-2".肥大细胞活化综合征的诊断:全球“共识-2”。
Diagnosis (Berl). 2020 Apr 22;8(2):137-152. doi: 10.1515/dx-2020-0005. Print 2021 May 26.
6
Recent advances in mast cell activation and regulation.肥大细胞激活与调控的最新进展。
F1000Res. 2020 Mar 19;9. doi: 10.12688/f1000research.22037.1. eCollection 2020.
7
Connectivity of depression symptoms before and after diagnosis of a chronic disease: A network analysis in the U.S. Health and Retirement Study.慢性疾病诊断前后抑郁症状的相关性:美国健康与退休研究中的网络分析。
J Affect Disord. 2020 Apr 1;266:230-234. doi: 10.1016/j.jad.2020.01.170. Epub 2020 Jan 29.
8
Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.为什么 20%+2 类胰蛋白酶公式是严重全身性肥大细胞激活和肥大细胞激活综合征的诊断金标准。
Int Arch Allergy Immunol. 2019;180(1):44-51. doi: 10.1159/000501079. Epub 2019 Jun 28.
9
Doctor, I Think I Am Suffering from MCAS: Differential Diagnosis and Separating Facts from Fiction.医生,我觉得我患有肥大细胞激活综合征(MCAS):鉴别诊断和厘清事实与虚构。
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1109-1114. doi: 10.1016/j.jaip.2018.11.045.
10
Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?近年来,我们对肥大细胞激活的认识不断深入——或者应该说是肥大细胞介质紊乱?
Expert Rev Clin Immunol. 2019 Jun;15(6):639-656. doi: 10.1080/1744666X.2019.1596800. Epub 2019 Apr 22.